BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8825871)

  • 1. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.
    Mastrangeli A; Harvey BG; Yao J; Wolff G; Kovesdi I; Crystal RG; Falck-Pedersen E
    Hum Gene Ther; 1996 Jan; 7(1):79-87. PubMed ID: 8825871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.
    Mack CA; Song WR; Carpenter H; Wickham TJ; Kovesdi I; Harvey BG; Magovern CJ; Isom OW; Rosengart T; Falck-Pedersen E; Hackett NR; Crystal RG; Mastrangeli A
    Hum Gene Ther; 1997 Jan; 8(1):99-109. PubMed ID: 8989999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.
    Harvey BG; Hackett NR; El-Sawy T; Rosengart TK; Hirschowitz EA; Lieberman MD; Lesser ML; Crystal RG
    J Virol; 1999 Aug; 73(8):6729-42. PubMed ID: 10400771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Brody SL; Metzger M; Danel C; Rosenfeld MA; Crystal RG
    Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circumventing the immune response to adenovirus-mediated gene therapy.
    Kass-Eisler A; Leinwand L; Gall J; Bloom B; Falck-Pedersen E
    Gene Ther; 1996 Feb; 3(2):154-62. PubMed ID: 8867863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.
    Yei S; Mittereder N; Tang K; O'Sullivan C; Trapnell BC
    Gene Ther; 1994 May; 1(3):192-200. PubMed ID: 7584081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G; Calmard L; Thouvenot D; Levrey H; Jagneaux V; Poitevin F; Malcus C; Accart N; Séné C; Layani MP; Aymard M; Bienvenu J; Courtney M; Döring G; Gilly B; Gilly R; Lamy D; Morel Y; Paulin C; Perraud F; Rodillon L; So S; Touraine F; Schatz C; Pavirani A
    C R Seances Soc Biol Fil; 1996; 190(1):109-42. PubMed ID: 8881273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.
    Harvey BG; Hackett NR; Ely S; Crystal RG
    Mol Ther; 2001 Feb; 3(2):206-15. PubMed ID: 11237677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for the respiratory manifestations of cystic fibrosis.
    Korst RJ; McElvaney NG; Chu CS; Rosenfeld MA; Mastrangeli A; Hay J; Brody SL; Eissa NT; Danel C; Jaffe HA
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
    Yei S; Mittereder N; Wert S; Whitsett JA; Wilmott RW; Trapnell BC
    Hum Gene Ther; 1994 Jun; 5(6):731-44. PubMed ID: 7948135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia.
    Johnson LG; Pickles RJ; Boyles SE; Morris JC; Ye H; Zhou Z; Olsen JC; Boucher RC
    Hum Gene Ther; 1996 Jan; 7(1):51-9. PubMed ID: 8825868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation.
    Setoguchi Y; Jaffe HA; Chu CS; Crystal RG
    Am J Respir Cell Mol Biol; 1994 Apr; 10(4):369-77. PubMed ID: 8136153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.
    Kaplan JM; St George JA; Pennington SE; Keyes LD; Johnson RP; Wadsworth SC; Smith AE
    Gene Ther; 1996 Feb; 3(2):117-27. PubMed ID: 8867859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated persistent cystic fibrosis transmembrane conductance regulator expression in mouse airway epithelium.
    Scaria A; St George JA; Jiang C; Kaplan JM; Wadsworth SC; Gregory RJ
    J Virol; 1998 Sep; 72(9):7302-9. PubMed ID: 9696826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung.
    Lee ER; Marshall J; Siegel CS; Jiang C; Yew NS; Nichols MR; Nietupski JB; Ziegler RJ; Lane MB; Wang KX; Wan NC; Scheule RK; Harris DJ; Smith AE; Cheng SH
    Hum Gene Ther; 1996 Sep; 7(14):1701-17. PubMed ID: 8886841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
    J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
    Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.
    Rosenfeld MA; Yoshimura K; Trapnell BC; Yoneyama K; Rosenthal ER; Dalemans W; Fukayama M; Bargon J; Stier LE; Stratford-Perricaudet L
    Cell; 1992 Jan; 68(1):143-55. PubMed ID: 1370653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.
    Harvey BG; Leopold PL; Hackett NR; Grasso TM; Williams PM; Tucker AL; Kaner RJ; Ferris B; Gonda I; Sweeney TD; Ramalingam R; Kovesdi I; Shak S; Crystal RG
    J Clin Invest; 1999 Nov; 104(9):1245-55. PubMed ID: 10545523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.